Acquisition - Schedule of Assets Acquired and Liabilities Assumed (Details) - Kezar Life Sciences, Inc. $ in Thousands |
May 11, 2026
USD ($)
|
|---|---|
| Asset Acquisition [Line Items] | |
| Cash and cash equivalents | $ 56,811 |
| Deferred tax assets | 23,128 |
| Interest receivable | 55 |
| Deferred tax benefits | (23,128) |
| Accounts payable and accrued expenses | (1,827) |
| Net assets acquired | 55,039 |
| Acquired in-process research and development | 449 |
| Total purchase consideration | $ 55,488 |
| X | ||||||||||
- Definition Asset Acquisition, Accounts Payable and Accruals, Current No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Accrued Interest Receivable, Current No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Assets Acquired And Liabilities Assumed, Net No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Cash And Equivalents No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Deferred Tax Asset No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Deferred Tax Benefits No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Intangible Asset Assumed, Acquired In Process Research And Development No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Recognized Asset Acquired, Net Assets No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|